LifeVantage to Announce Third Quarter Fiscal Year 2022 Results on May 3, 2022

Rhea-AI Summary

LifeVantage Corporation (Nasdaq: LFVN) will release its financial results for the third quarter ending March 31, 2022, on May 3, 2022, after market close. A conference call for investors will take place at 2:30 p.m. MT (4:30 p.m. ET) on the same day. Interested participants can join via phone or a live webcast, which will also be available for replay until May 10, 2022. LifeVantage specializes in nutrigenomics, offering products like Protandim® and other dietary supplements aimed at promoting health and wellness.

SALT LAKE CITY, April 19, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its third quarter ended March 31, 2022, after the stock market closes on Tuesday, May 3, 2022. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Tuesday, May 10, 2022, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13728413, or (412) 317-6671 from international locations, and entering confirmation code 13728413.

There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1539820&tp_key=3e6fdb8400. The webcast will be archived for approximately 30 days.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+™, ProBio™, and Daily Wellness™ dietary supplements, TrueScience® is the Company's line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ™, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com

 

FAQ

When will LifeVantage release its Q3 financial results for 2022?

LifeVantage will release its Q3 financial results on May 3, 2022, after market close.

What time is the LifeVantage investor conference call scheduled for?

The investor conference call is scheduled for 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on May 3, 2022.

How can I participate in the LifeVantage conference call?

Participants can join the conference call by dialing (877) 704-4453 for U.S. callers or (201) 389-0920 for international callers.

Will there be a replay available for the LifeVantage conference call?

Yes, a replay will be available approximately two hours after the call concludes until May 10, 2022.

Where can I find more information about LifeVantage's products?

You can find more information about LifeVantage and its products by visiting their official website at www.lifevantage.com.